We are thrilled to share some exciting news: Mecwins, in collaboration with Destina Genómica, has been awarded funding under the Spanish Program “MISIONES DE CIENCIA E INNOVACIÓN”, granted by the Centro para el Desarrollo Tecnológico y la Innovación (CDTI).
This support will enable us to develop “New multi-analyte biosensor technology for the early detection of breast cancer through liquid biopsy”, a joint project aimed at advancing more precise, accessible, and non-invasive tools for early diagnosis.
With a grant of €611,478.85, we take another step forward in our mission to transform scientific innovation into real healthcare solutions. Together with Destina Genómica, we remain committed to bringing cutting-edge technology closer to those who need it most.
Thank you for joining us on this journey toward the future of breast cancer early detection!
